Free tool
Stocks far below their 52-week high
We cover 163 companies trading at least 50% below their own 52-week high. The median market value in the group is $289.93M. Across the group, the median move over the past trading day is −0.28%. 9% of the 160 with a 200-day average trade above it. Price change over the past year runs from −69.6% to +49.1% across the middle 80 percent of the group, with a median of −40.8%.
Other lists in this group
Table
163 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| PODD | Insulet Corporation | $143.38 | −14.38% | −49.32% | −57.12% |
| HIMS | Hims & Hers Health, Inc. | $29.83 | +1.74% | −10.72% | −32.22% |
| COH.AX | Cochlear Limited | 136.01 AUD | +11.03% | −47.23% | −53.79% |
| DOCS | Doximity, Inc. | $24.74 | +15.39% | −42.85% | −63.61% |
| 4506.T | Sumitomo Pharma Co., Ltd. | 1,436.50 JPY | +13.47% | −41.63% | −3.59% |
| RGC | Regencell Bioscience Holdings Limited | $5.50 | −7.87% | −73.22% | −61.38% |
| EBO.AX | EBOS Group Limited | 17.51 AUD | −7.26% | −23.87% | −37.83% |
| ADMA | ADMA Biologics, Inc. | $9.63 | +9.56% | −46.14% | −44.17% |
| NTLA | Intellia Therapeutics, Inc. | $13.19 | +21.12% | +43.21% | +15.50% |
| RXRX | Recursion Pharmaceuticals, Inc. | $3.49 | +14.43% | −16.90% | −28.63% |
| INSP | Inspire Medical Systems, Inc. | $61.80 | +18.91% | −33.02% | −33.04% |
| 4DX.AX | 4DMedical Limited | 3.70 AUD | +13.34% | −18.61% | +669.79% |
| AAPG | Ascentage Pharma Group Internat | $16.90 | −7.57% | −35.91% | −59.18% |
| ATEC | Alphatec Holdings, Inc. | $9.42 | +1.07% | −54.62% | −41.78% |
| P1RG34.SA | Perrigo Company plc | 50.71 BRL | −1.59% | −31.71% | −59.77% |
| MLTX | MoonLake Immunotherapeutics | $15.62 | −16.52% | +30.71% | −71.82% |
| VOR | Vor Biopharma Inc. | $23.67 | +18.35% | +103.35% | −40.82% |
| PRCT | PROCEPT BioRobotics Corporation | $21.07 | +16.54% | −31.50% | −48.36% |
| WVE | Wave Life Sciences, Inc. | $5.23 | −11.21% | −67.21% | −48.12% |
| QDEL | QuidelOrtho Corporation | $14.91 | −10.56% | −48.19% | −46.31% |
| ARDX | Ardelyx, Inc. | $3.83 | −24.68% | −37.72% | −38.13% |
| OLMA | Olema Pharmaceuticals, Inc. | $10.85 | −6.63% | −57.08% | +89.02% |
| AHG | Akso Health Group | $0.99 | −32.19% | −38.12% | −43.10% |
| AHCO | AdaptHealth Corp. | $5.67 | −49.47% | −41.37% | −38.44% |
| D2OC34.SA | Doximity, Inc. | 21.20 BRL | +16.10% | −48.15% | −65.76% |
| CTMX | CytomX Therapeutics, Inc. | $3.32 | +3.11% | −21.88% | +60.39% |
| OCS | Oculis Holding AG | $12.97 | +17.32% | −35.15% | −25.14% |
| PHR | Phreesia, Inc. | $11.60 | +6.81% | −28.83% | −63.74% |
| SSII | SS Innovations International, Inc. | $3.57 | −9.16% | −36.81% | −50.55% |
| PHAT | Phathom Pharmaceuticals, Inc. | $8.77 | −24.79% | −44.18% | −29.50% |
| ALLO | Allogene Therapeutics, Inc. | $2.04 | +22.89% | +51.11% | +75.86% |
| EVT.DE | Evotec SE | 3.25 EUR | −6.22% | −41.07% | −45.75% |
| PROK | ProKidney Corp. | $1.74 | +12.99% | −21.97% | −30.12% |
| EVO | Evotec SE | $1.95 | −0.51% | −38.68% | −44.13% |
| 2HQ0.DE | Tilray Brands, Inc. | 4.07 EUR | +21.13% | −48.80% | −67.56% |
| TLRY.TO | Tilray Brands, Inc. | 6.46 CAD | +13.73% | −51.61% | +240.00% |
| TLRY | Tilray Brands, Inc. | $4.64 | +15.14% | −52.26% | −66.13% |
| CU6.AX | Clarity Pharmaceuticals Ltd | 2.37 AUD | +13.16% | −36.25% | −25.63% |
| ALT | Altimmune, Inc. | $3.15 | +5.35% | −10.26% | −14.17% |
| MPLT | MapLight Therapeutics, Inc. | $12.86 | +4.47% | −23.32% | −29.88% |
| CRW.L | Craneware plc | 1,272.00 GBP | +2.75% | −33.40% | −40.83% |
| SPRY | ARS Pharmaceuticals, Inc. | $6.03 | +6.35% | −47.52% | −55.13% |
| EVH | Evolent Health, Inc. | $4.92 | +31.55% | +26.48% | −48.86% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | 13,370.00 KRW | +23.80% | −43.35% | −40.58% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $7.23 | −6.10% | −16.90% | −41.46% |
| EVMN | Evommune, Inc. | $14.11 | +25.42% | −18.49% | −30.25% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | 1.04 EUR | +0.97% | −90.91% | −90.91% |
| 4592.T | SanBio Company Limited | 997.00 JPY | +10.78% | −39.10% | −57.08% |
| CGC | Canopy Growth Corporation | $1.04 | +15.77% | −13.03% | −31.46% |
| WEED.TO | Canopy Growth Corporation | 1.43 CAD | +13.49% | −12.80% | −31.25% |
| RZLT | Rezolute, Inc. | $5.04 | +2.44% | +132.79% | −30.00% |
| 317450.KS | MYUNGIN PHARM | 45,750.00 KRW | +14.09% | −25.73% | −55.96% |
| CAPR | Capricor Therapeutics, Inc. | $9.36 | +42.47% | −66.94% | +49.76% |
| AGY.L | Allergy Therapeutics plc | 5.60 GBP | −5.08% | −52.94% | −30.00% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | 3.45 BRL | +8.15% | −44.80% | −1.57% |
| BIOA | BioAge Labs, Inc. | $9.84 | −55.11% | −23.30% | +107.59% |
| CMPX | Compass Therapeutics, Inc. | $2.43 | +19.12% | −53.00% | −25.91% |
| EYPT | EyePoint, Inc. | $4.99 | −58.28% | −71.45% | −57.85% |
| LXEO | Lexeo Therapeutics, Inc. | $5.01 | +14.12% | −47.87% | +3.30% |
| UPB | Upstream Bio, Inc. | $7.13 | +11.41% | −73.66% | −57.31% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | 1.92 BRL | +214.75% | −29.41% | −33.79% |
| LYEL | Lyell Immunopharma, Inc. | $15.49 | +19.25% | −46.55% | +37.32% |
| N3B.F | Anbio Biotechnology | 6.40 EUR | −24.26% | −62.13% | −83.42% |
| STRO | Sutro Biopharma, Inc. | $21.43 | −9.69% | +95.53% | +138.11% |
| NNNN | Anbio Biotechnology | $7.72 | −23.94% | −73.81% | −83.55% |
| 249420.KS | Ildong Pharmaceutical Co., Ltd. | 14,450.00 KRW | +18.93% | −62.41% | −40.38% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | 13.50 EUR | +8.87% | −48.77% | +47.70% |
| RAC.AX | Racura Oncology Ltd | 2.23 AUD | +12.06% | −22.30% | +87.39% |
| YDES | YD Bio Ltd | $4.34 | +88.70% | −63.83% | −63.83% |
| EBS | Emergent BioSolutions Inc. | $5.97 | −18.33% | −52.28% | −30.50% |
| BCYC | Bicycle Therapeutics plc | $4.36 | +10.53% | −34.81% | −37.79% |
| AVXL | Anavex Life Sciences Corp. | $3.24 | +26.07% | −11.96% | −65.71% |
| 4894.T | Cuorips Inc. | 5,720.00 JPY | +35.06% | −8.04% | −15.38% |
| MYGN | Myriad Genetics, Inc. | $3.12 | −41.35% | −49.19% | −47.39% |
| TRDA | Entrada Therapeutics, Inc. | $7.00 | +20.07% | −30.35% | +23.24% |
| FULC | Fulcrum Therapeutics, Inc. | $3.86 | +3.76% | −64.65% | −41.78% |
| 003000.KS | Bukwang Pharmaceutical Co., Ltd. | 4,110.00 KRW | +12.14% | +7.31% | +26.14% |
| NMRA | Neumora Therapeutics, Inc. | $1.56 | −7.14% | −6.02% | −11.36% |
| 0120G0.KS | Samyang Biopharm | 54,100.00 KRW | +52.39% | +4.04% | +79.14% |
| TTRX | Turn Therapeutics Inc. | $9.63 | +25.06% | +105.33% | +37.57% |
| CV | CapsoVision, Inc. | $5.82 | −12.08% | −43.16% | +46.97% |
| 7777.T | 3-D Matrix, Ltd. | 361.00 JPY | +13.88% | −0.55% | +68.69% |
| EMBC | Embecta Corp. | $4.96 | +38.16% | −56.84% | −64.70% |
| SION | Sionna Therapeutics, Inc. | $6.17 | −86.75% | −84.26% | −75.45% |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% |
| 950210.KS | Prestige BioPharma Limited | 6,150.00 KRW | +10.81% | −54.65% | −55.91% |
| IVVD | Invivyd, Inc. | $0.90 | +52.06% | −63.93% | +3.52% |
| RXST | RxSight, Inc. | $6.38 | +5.45% | −38.54% | −25.38% |
| NAGE | Niagen Bioscience, Inc. | $3.30 | +0.30% | −47.20% | −66.22% |
| NERV | Minerva Neurosciences, Inc. | $5.43 | +26.87% | +38.52% | +129.11% |
| LAB | Standard BioTools Inc. | $0.65 | −17.49% | −48.68% | −49.08% |
| AKBA | Akebia Therapeutics, Inc. | $0.91 | −28.62% | −41.52% | −69.88% |
| 4593.T | Healios K.K. | 286.00 JPY | +34.91% | +1.78% | −41.63% |
| PEPG | PepGen Inc. | $3.22 | +75.96% | −55.09% | +159.68% |
| TNXP | Tonix Pharmaceuticals Holding Corp. Common Stock | $13.64 | +37.22% | −17.58% | −57.61% |
| HLS.AX | Healius Limited | 0.45 AUD | +20.00% | −50.55% | −50.55% |
| TARA | Protara Therapeutics, Inc. | $3.91 | −0.76% | −27.32% | +21.05% |
| TSND.TO | TerrAscend Corp. | 0.85 CAD | +23.19% | −19.05% | −44.44% |
| ORGO | Organogenesis Holdings Inc. | $1.75 | −30.83% | −62.24% | −63.84% |
| NGEN | NervGen Pharma Corp. | $2.21 | +37.27% | −62.41% | −8.30% |
| SIGA | SIGA Technologies, Inc. | $3.07 | −8.08% | −44.65% | −57.93% |
| KROS | Keros Therapeutics, Inc. | $11.12 | +10.43% | −40.02% | −28.35% |
| NBP | NovaBridge Biosciences | $1.87 | +6.86% | −56.21% | −58.44% |
| ZJYL | Jin Medical International Ltd. | $2.79 | +45.31% | −38.00% | −82.97% |
| ARMP | Armata Pharmaceuticals, Inc. | $5.45 | +15.22% | −16.92% | +123.36% |
| KRRO | Korro Bio, Inc. | $13.68 | +30.29% | +69.94% | −36.61% |
| AIRS | AirSculpt Technologies, Inc. | $2.72 | −41.63% | +47.03% | −57.30% |
| HUMA | Humacyte, Inc. | $0.68 | +8.02% | −30.09% | −55.45% |
| AIDX.TO | Healwell AI Inc. | 0.79 CAD | +20.77% | −6.55% | −40.08% |
| MYX.AX | Mayne Pharma Group Limited | 3.15 AUD | +19.32% | −1.25% | −37.38% |
| CNTN | Canton Strategic Holdings, Inc. | $2.23 | +9.31% | −34.02% | −55.04% |
| SPRB | Spruce Biosciences, Inc. | $61.48 | +47.79% | −32.22% | +721.93% |
| WW | WW International, Inc. | $17.60 | +27.91% | −44.02% | −45.96% |
| QSI | Quantum-Si incorporated | $0.79 | +3.89% | −31.84% | −31.84% |
| SANION.ST | Saniona AB (publ) | 11.83 SEK | −15.32% | −43.93% | −12.37% |
| MENS | Jyong Biotech Ltd. | $2.24 | −6.28% | −34.31% | −95.62% |
| PGC.AX | Paragon Care Limited | 0.14 AUD | +13.60% | −35.45% | −58.24% |
| NYXH | Nyxoah SA | $1.62 | +13.29% | −64.00% | −73.74% |
| ALSEN.PA | Sensorion SA | 0.28 EUR | −0.71% | −17.01% | −14.20% |
| 504A.T | Innovacell Inc. | 570.00 JPY | +3.07% | −45.71% | −45.71% |
| LFMD | LifeMD, Inc. | $3.24 | −15.62% | −7.16% | −49.45% |
| TNYA | Tenaya Therapeutics, Inc. | $0.70 | −7.91% | −5.28% | −36.71% |
| SPRC | SciSparc Ltd. | $6.74 | +26.45% | −46.51% | −82.42% |
| EBR.AX | EBR Systems, Inc. | 0.29 AUD | +4.36% | −68.63% | −78.74% |
| OTLK | Outlook Therapeutics, Inc. | $0.62 | −31.05% | −5.56% | −73.76% |
| 003520.KS | Yungjin Pharm. Co., Ltd. | 1,139.00 KRW | +0.44% | −43.75% | −43.89% |
| OWLT | Owlet, Inc. | $5.16 | −0.19% | −68.09% | −28.43% |
| AARD | Aardvark Therapeutics, Inc. | $6.81 | +6.07% | −48.37% | −24.25% |
| OCC.AX | Orthocell Limited | 0.76 AUD | +6.29% | −32.14% | −36.67% |
| CRNO-B.ST | Cereno Scientific AB (publ) | 4.71 SEK | +0.13% | −32.04% | −53.59% |
| KRMD | KORU Medical Systems, Inc. | $3.21 | −19.95% | −42.78% | −24.47% |
| MIST | Milestone Pharmaceuticals Inc. | $1.18 | +10.28% | −42.44% | −33.33% |
| LENZ | LENZ Therapeutics, Inc. | $4.78 | −18.71% | −70.12% | −87.21% |
| OPRX | OptimizeRx Corporation | $7.75 | +22.24% | −37.60% | −55.79% |
| INDP | Indaptus Therapeutics, Inc. | $1.14 | −34.10% | −58.39% | −82.19% |
| STXS | Stereotaxis, Inc. | $1.45 | +13.28% | −37.50% | −49.48% |
| TLSA | Tiziana Life Sciences Ltd | $1.09 | +12.37% | −31.87% | −41.08% |
| SCLP.L | Scancell Holdings plc | 9.70 GBP | −2.02% | −2.02% | −7.62% |
| 004310.KS | Hyundai Pharmaceutical Co., Ltd. | 6,020.00 KRW | +22.61% | −33.31% | +51.26% |
| INO | Inovio Pharmaceuticals, Inc. | $1.30 | +26.21% | −23.08% | −47.15% |
| ADCT | ADC Therapeutics SA | $1.05 | −5.41% | −70.17% | −67.39% |
| ENGN | enGene Therapeutics Inc. | $1.95 | +10.80% | −77.97% | −55.07% |
| BDTX | Black Diamond Therapeutics, Inc. | $2.27 | +28.98% | −8.84% | −20.91% |
| CBUS | Cibus, Inc. | $1.68 | −13.40% | −10.64% | +27.27% |
| QTRX | Quanterix Corporation | $2.68 | −23.21% | −58.32% | −41.87% |
| GUTS | Fractyl Health, Inc. | $0.74 | +1.95% | −67.24% | −25.55% |
| GNLX | Genelux Corporation | $2.73 | −6.51% | −40.00% | −25.00% |
| DXB.AX | Dimerix Limited | 0.29 AUD | +20.83% | −47.27% | −34.83% |
| NTHI | NeOnc Technologies Holdings, Inc. | $4.56 | +30.66% | −48.65% | −29.30% |
| ONE.AX | Oneview Healthcare PLC | 0.19 AUD | +26.67% | −51.90% | −15.56% |
| HCAT | Health Catalyst, Inc. | $1.59 | −25.70% | −30.26% | −56.91% |
| RANI | Rani Therapeutics Holdings, Inc. | $0.84 | +2.74% | −38.13% | +49.45% |
| QUCY | Quantum Cyber N.V. | $1.38 | +26.15% | +18.53% | −15.12% |
| GBT.PA | Guerbet SA | 7.92 EUR | +3.80% | −46.41% | −61.92% |
| NAUT | Nautilus Biotechnology, Inc. | $0.94 | −21.88% | −50.92% | +33.34% |
| FARON.HE | Faron Pharmaceuticals Oy | 0.48 EUR | −0.92% | −78.79% | −79.42% |
| FARN.L | Faron Pharmaceuticals Oy | 41.00 GBP | −4.65% | −78.97% | −79.24% |
| BNR | Burning Rock Biotech Limited | $10.44 | +13.60% | −46.95% | +22.54% |
| HBP.TO | Helix BioPharma Corp. | 1.94 CAD | +33.79% | −19.17% | +46.97% |
| BGM | BGM Group Ltd. | $0.27 | −3.58% | −92.32% | −96.61% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.70 SEK | −12.97% | −47.45% | −60.78% |
| EAPI.PA | Euroapi S.A. | 0.95 EUR | −24.88% | −56.91% | −68.63% |
| MBOT | Microbot Medical Inc. | $1.52 | −9.52% | −27.96% | −62.65% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.